Location History:
- Lucerne, CH (1976 - 2015)
- Weggis, CH (2011 - 2024)
Company Filing History:
17 out of 24 
17 out of 30 
11 out of 33 Years Active: 1976-2024
Areas of Expertise:
Title: Rolf Wilhelm Pfirrmann: A Pioneer in Oxathiazin-Like Compounds
Introduction
Rolf Wilhelm Pfirrmann, based in Lucerne, Switzerland, is a distinguished inventor recognized for his significant contributions to the field of chemistry, particularly in the development of oxathiazin-like compounds. With an impressive portfolio of 46 patents, Pfirrmann has made notable strides in creating processes and compounds that have vast potential applications in medicine.
Latest Patents
His latest patents revolve around the preparation of oxathiazin-like compounds. The inventions disclose innovative processes for creating new oxathiazin-like compounds, which are particularly useful in treating patients suffering from cancers, bacterial infections, fungal infections, and viral infections. One of the remarkable findings includes the demonstration that these compounds exhibit significantly longer half-lives compared to established compounds like taurolidine and taurultam. Additionally, the methodologies outlined in his patents detail a specific process for producing these compounds, involving the reaction of sodium 2-bromoethanesulfonate with benzyl alcohol and sodium benzyloxide, among other steps, ultimately leading to useful solid derivatives.
Career Highlights
Throughout his career, Rolf Wilhelm Pfirrmann has held pivotal roles in research and development. He has worked with esteemed organizations such as Ed. Geistlich Sohne AG für Chemische Industrie, where he contributed to advancing chemical processes and products. His diligent efforts have placed him as a leading figure in his area of expertise, firmly establishing his reputation in the scientific community.
Collaborations
Pfirrmann has worked alongside notable colleagues such as H. Paul Redmond and Peter Geistlich. These collaborations have been essential in pushing the boundaries of research and fostering innovation in their shared endeavors, ultimately leading to groundbreaking advancements in the medical application of oxathiazin-like compounds.
Conclusion
Rolf Wilhelm Pfirrmann continues to be an influential inventor in the realm of oxathiazin-like compounds. His innovative patents and collaborative efforts have not only enriched the scientific community but have also paved the way for potential breakthroughs in treatment methodologies for various ailments. His legacy serves as an inspiration for future innovators and researchers in the field of chemistry and medicinal applications.